APA aipamena

Baumgart, S. J., Nevedomskaya, E., Lesche, R., Newman, R., Mumberg, D., & Haendler, B. (2020). Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation. Mol Oncol.

Chicago Style aipamena

Baumgart, Simon J., Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, and Bernard Haendler. "Darolutamide Antagonizes Androgen Signaling By Blocking Enhancer and Super‐enhancer Activation." Mol Oncol 2020.

MLA aipamena

Baumgart, Simon J., et al. "Darolutamide Antagonizes Androgen Signaling By Blocking Enhancer and Super‐enhancer Activation." Mol Oncol 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.